Skip to main content
. 2014 May 27;2(2):397–421. doi: 10.3390/vaccines2020397

Figure 4.

Figure 4

The long-term outcome using the sample values in Table 1 for the case when Mutant 1 has 10-fold resistance and Mutant 2 has 100-fold resistance (pM1 = 0.1pW, pM2 = 0.01pW) as the antibody magnification factor m varies. (A) m = 1; (B) m = 10; (C) m = 50.